Applied Therapeutics Inc (NASDAQ:APLT) shares, rose in value on Thursday, July 10, with the stock price up by 4.84% to the previous day’s close as strong demand from buyers drove the stock to $0.41.
Actively observing the price movement in the last trading, the stock closed the session at $0.4, falling within a range of $0.3902 and $0.4141. The value of beta (5-year monthly) was 1.874. Referring to stock’s 52-week performance, its high was $10.62, and the low was $0.29. On the whole, APLT has fluctuated by 4.84% over the past month.
With the market capitalization of Applied Therapeutics Inc currently standing at about $58.62 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that APLT’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of APLT currently trading nearly 18.17% and 6.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 58.89, while the 7-day volatility ratio is showing 9.48% which for the 30-day chart, stands at 9.74%. Furthermore, Applied Therapeutics Inc (APLT)’s beta value is 1.93.
A comparison of Applied Therapeutics Inc (APLT) with its peers suggests the former has fared considerably weaker in the market. APLT showed an intraday change of 4.84% in last session, and over the past year, it shrunk by -51.64%%.
Data on historical trading for Applied Therapeutics Inc (NASDAQ:APLT) indicates that the trading volumes over the past 10 days have averaged 3.53 and over the past 3 months, they’ve averaged 2.36 million. According to company’s latest data on outstanding shares, there are 141.58 million shares outstanding.
Nearly 17.70% of Applied Therapeutics Inc’s shares belong to company insiders and institutional investors own 74.84% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 21.33 million shares as on 2025-06-13, resulting in a short ratio of 8.79. According to the data, the short interest in Applied Therapeutics Inc (APLT) stood at 1517.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 19.79 million. The stock has fallen by -91.48% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the APLT stock heading into the next quarter.
